We are live on
!
Find out more
Sands Capital Management Portfolio holdings
AUM
$25.5B
1-Year Est. Return
26.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.63%
1 Year Est. Return
+26.46%
3 Year Est. Return
+130.81%
5 Year Est. Return
+100.92%
10 Year Est. Return
+877.17%
AUM
$33.3B
AUM Growth
+$1.42B
(+4.5%)
Cap. Flow
-$1.29B
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
51.59%
Holding
70
New
3
Increased
19
Reduced
46
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Incyte
INCY
|
+$475M |
| 2 |
CoStar Group
CSGP
|
+$204M |
| 3 |
Starbucks
SBUX
|
+$200M |
| 4 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$180M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$419M |
| 2 |
SLB Ltd
SLB
|
+$393M |
| 3 |
Booking.com
BKNG
|
+$322M |
| 4 |
Biogen
BIIB
|
+$317M |
| 5 |
Amazon
AMZN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.54% |
| 2 | Communication Services | 21.15% |
| 3 | Healthcare | 18.77% |
| 4 | Technology | 15.82% |
| 5 | Financials | 11.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Visa
V
$697B
| $2.36B | 7.09% |
25,156,197
-4,510,855
| -15% | -$419M |
|
2
Alibaba
BABA
$276B
| $2.3B | 6.92% |
16,326,315
-927,040
| -5% | -$114M |
|
3
Meta Platforms (Facebook)
META
$1.51T
| $2.27B | 6.82% |
15,016,510
-1,107,702
| -7% | -$165M |
|
|
4
Booking.com
BKNG
$154B
| $1.92B | 5.76% |
25,624,425
-4,391,275
| -15% | -$322M |
|
|
5
Amazon
AMZN
$2.48T
| $1.89B | 5.69% |
39,094,700
-4,513,980
| -10% | -$215M |
|
6
Regeneron Pharmaceuticals
REGN
$72.9B
| $1.37B | 4.13% |
2,793,959
-139,485
| -5% | -$61M |
|
7
Alphabet (Google) Class A
GOOGL
$4.08T
| $1.37B | 4.11% |
29,390,580
-1,997,780
| -6% | -$93.4M |
|
8
Baidu
BIDU
$35.6B
| $1.25B | 3.76% |
6,986,910
+621,581
| +10% | +$113M |
|
9
Salesforce
CRM
$149B
| $1.24B | 3.72% |
14,293,984
-1,272,889
| -8% | -$111M |
|
|
SCHW
10
Charles Schwab
SCHW
$184B
| $1.2B | 3.6% |
27,875,653
-1,278,645
| -4% | -$51.2M |
|
11
Netflix
NFLX
$301B
| $1.13B | 3.39% |
75,559,080
-4,970,560
| -6% | -$76.5M |
|
|
12
Incyte
INCY
$26B
| $1.01B | 3.02% |
7,983,826
+3,733,233
| +88% | +$475M |
|
13
Adobe
ADBE
$99B
| $934M | 2.81% |
6,606,858
-1,405,478
| -18% | -$192M |
|
14
Illumina
ILMN
$29.2B
| $905M | 2.72% |
5,364,332
-284,804
| -5% | -$49.3M |
|
15
Edwards Lifesciences
EW
$48.2B
| $903M | 2.71% |
22,899,525
-1,122,084
| -5% | -$41M |
|
16
BioMarin Pharmaceuticals
BMRN
$12B
| $772M | 2.32% |
8,505,481
-466,924
| -5% | -$42.5M |
|
|
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
| $772M | 2.32% |
6,346,074
+1,110,444
| +21% | +$129M |
|
|
18
Starbucks
SBUX
$118B
| $752M | 2.26% |
12,891,454
+3,308,429
| +35% | +$200M |
|
|
19
Alphabet (Google) Class C
GOOG
$4.07T
| $695M | 2.09% |
15,298,920
-942,760
| -6% | -$43.2M |
|
20
ServiceNow
NOW
$114B
| $663M | 1.99% |
31,292,350
+5,110,770
| +20% | +$100M |
|
21
Monster Beverage
MNST
$95.6B
| $565M | 1.7% |
22,730,032
-2,027,158
| -8% | -$48.8M |
|
22
Workday
WDAY
$39.4B
| $548M | 1.65% |
5,645,989
-35,581
| -0.6% | -$3.32M |
|
23
Chipotle Mexican Grill
CMG
$43B
| $528M | 1.59% |
63,480,250
-16,004,100
| -20% | -$149M |
|
24
ASML
ASML
$608B
| $517M | 1.55% |
3,963,734
-586,272
| -13% | -$77.6M |
|
|
SPLK
25
DELISTED
Splunk Inc
SPLK
| $494M | 1.49% |
8,691,233
-776,101
| -8% | -$48.3M |
|
Similar funds
KK
VAI
UIM
SO
Sands Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Sands Capital Management held 70 positions worth $33.3B, up 4.5% from $31.8B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Sands Capital Management withdrew a net $1.29B in Q2 2017, closing 1 position and reducing 46 holdings. Its most notable exit was SLB Ltd, an estimated $393M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, up from 26% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Sands Capital Management opened a new position in Lakefront Biotherapeutics American Depositary Shares worth $164M.
- Sands Capital Management's largest Q2 2017 buy was Lakefront Biotherapeutics American Depositary Shares: 2,138,491 shares worth $164M.
- Sands Capital Management added most to Incyte in Q2 2017, an estimated $475M increase.
- Sands Capital Management's biggest Q2 2017 reduction was Visa, cutting an estimated $419M.
- Sands Capital Management fully exited SLB Ltd in Q2 2017, selling an estimated $393M.
- Sands Capital Management's ten largest holdings make up 52% of its $33.3B portfolio in Q2 2017.
- Sands Capital Management opened 3 new positions and closed 1 in Q2 2017.
- Sands Capital Management's portfolio value rose 4.5% quarter-over-quarter to $33.3B.
Based on Sands Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.